Literature DB >> 34265246

SnapShot: SARS-CoV-2 antibodies.

David C Montefiori1, Priyamvada Acharya1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34265246      PMCID： PMC8279512          DOI： 10.1016/j.chom.2021.06.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


× No keyword cloud information.
  6 in total

1.  Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.

Authors:  Alexandra Schäfer; David R Martinez; John J Won; Fernando R Moreira; Ariane J Brown; Kendra L Gully; Rao Kalla; Kwon Chun; Venice Du Pont; Darius Babusis; Jennifer Tang; Eisuke Murakami; Raju Subramanian; Kimberly T Barrett; Blake J Bleier; Roy Bannister; Joy Y Feng; John P Bilello; Tomas Cihlar; Richard L Mackman; Stephanie A Montgomery; Ralph S Baric; Timothy P Sheahan
Journal:  bioRxiv       Date:  2021-09-17

2.  Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth.

Authors:  Zhiqiang Ku; Xuping Xie; Jianqing Lin; Peng Gao; Abbas El Sahili; Hang Su; Yang Liu; Xiaohua Ye; Xin Li; Xuejun Fan; Boon Chong Goh; Wei Xiong; Hannah Boyd; Antonio E Muruato; Hui Deng; Hongjie Xia; Zou Jing; Birte K Kalveram; Vineet D Menachery; Ningyan Zhang; Julien Lescar; Pei-Yong Shi; Zhiqiang An
Journal:  bioRxiv       Date:  2022-02-01

3.  Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients.

Authors:  Juliette Gueguen; Charlotte Colosio; Arnaud Del Bello; Anne Scemla; Yohan N'Guyen; Claire Rouzaud; Claudia Carvalho-Schneider; Gabriela Gautier Vargas; Pierre Tremolières; A Jalal Eddine; Christophe Masset; Olivier Thaunat; Melchior Chabannes; Paulo Malvezzi; Pierre Pommerolle; Lionel Couzi; Nassim Kamar; Sophie Caillard; Philippe Gatault
Journal:  Kidney Int Rep       Date:  2022-03-26

Review 4.  Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.

Authors:  Mohammad Reza Zinatizadeh; Peyman Kheirandish Zarandi; Maryam Zinatizadeh; Mohammad Hadi Yousefi; Jaffar Amani; Nima Rezaei
Journal:  Biomed Pharmacother       Date:  2021-12-10       Impact factor: 7.419

Review 5.  How concerning is a SARS-CoV-2 variant of concern? Computational predictions and the variants labeling system.

Authors:  Dana Ashoor; Maryam Marzouq; Khaled Trabelsi; Sadok Chlif; Nasser Abotalib; Noureddine Ben Khalaf; Ahmed R Ramadan; M-Dahmani Fathallah
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

6.  Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern.

Authors:  Wenwei Li; Yaozong Chen; Jérémie Prévost; Irfan Ullah; Maolin Lu; Shang Yu Gong; Alexandra Tauzin; Romain Gasser; Dani Vézina; Sai Priya Anand; Guillaume Goyette; Debashree Chaterjee; Shilei Ding; William D Tolbert; Michael W Grunst; Yuxia Bo; Shijian Zhang; Jonathan Richard; Fei Zhou; Rick K Huang; Lothar Esser; Allison Zeher; Marceline Côté; Priti Kumar; Joseph Sodroski; Di Xia; Pradeep D Uchil; Marzena Pazgier; Andrés Finzi; Walther Mothes
Journal:  bioRxiv       Date:  2021-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.